Weight-loss drugs
The latest news about Weight-loss drugs: headlines, AI summaries and the full story from every source.
- US Markets Recover from Post-Election Slump Amid Positive Clinical Trial Data for Eli Lilly and Johnson & Johnson
- Novo Nordisk Reports Strong Third Quarter Results Driven by Oral Wegovy Growth
- Novo Nordisk Raises Annual Outlook Amid Strong Demand for Wegovy and Ozempic
- Novo Nordisk Raises Full-Year Outlook Following Strong Wegovy Sales
- Eli Lilly Reports Strong Q3 Results Driven by Mounjaro and Jardiance Growth
- Eli Lilly Raises Full-Year Revenue Outlook Driven by Strong Weight-Loss Drug Demand
- US Judge Denies Novo Nordisk Request to Halt Eli Lilly Weight-Loss Drug Advertisements
- WHO Recommends Lifestyle Changes Over GLP-1 Drugs for Child Obesity
- Eli Lilly Expands Weight Loss Drug Access to Low- and Middle-Income Countries
- Novo Nordisk Considers Acquisitions Amid Intensifying Competition for Weight-Loss Drugs
- Novo Nordisk CEO Signals Interest in M&A to Bolster Drug Pipeline
- Berenberg Upgrades Eli Lilly to Buy, Citing Potential for Exceeding 2026 Guidance
- Eli Lilly Stock Hits All-Time High Amid Positive Outlook from Analyst
- Artificial Intelligence Opportunity in Healthcare: 3 Stocks to Watch
- Employers Reduce Coverage of Weight-Loss Drugs Amid Rising Costs
- CVS Health Restores Coverage for Eli Lilly's Zepbound
- Eli Lilly Reports Strong Earnings and Raises Outlook Amid Surge in Weight-Loss Drug Demand
- Eli Lilly Stock Rises Due to Weight-Loss Drug Results; Caterpillar and Google Also See Gains
- Pfizer's GLP-1 Drug May Challenge Novo Nordisk and Eli Lilly's Market Dominance